Dr. Malarkannan Brings Immunology Expertise To UW

We’re pleased to share Dr. Subramaniam Malarkannan (“Malar”) will join the UW Carbone Cancer Center and Division of Hematology, Medical Oncology and Palliative Care as a visiting professor on Jan. 1, 2027. He was recruited through the UW RISE-THRIVE initiative.
Dr. Malarkannan completed his PhD at Madurai Kamaraj University in India followed by post-doctoral training at UC-Berkeley. He then joined the faculty in Milwaukee where he is currently s Professor of Medicine at the Medical College of WI and a Senior Investigator and Endowed Chair for Immunotherapy at the Versiti Blood Research Institute. He is an accomplished immunologist whose research has focused on the basic biology and clinical application of natural killer (NK) cells. His laboratory has advanced the field’s understanding of NK-cell development, maturation, signaling, metabolism, and antitumor function and role in GVHD. Throughout his career, he has also excelled in mentorship and leadership.
His recruitment through the RISE-THRIVE initiative is an exciting addition to our growing strengths in immunology, cellular therapy, translational science, and cancer research. His scientific expertise should create important opportunities for collaboration across HOPC, UW Carbone, and the broader UW research community.
Dr. Malarkannan visited UW in July and presented a talk, “From NK Cell Development to Trained Immunity: Implications for Graft-versus-Host Disease.”